Showing results (431-440 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|August 30, 2016
Sudden unexpected death in epilepsy: epidemiology, mechanisms, and preventionOrrin Devinsky, Dale C Hesdorffer, David J Thurman, et al.
The Lancet. Neurology|August 30, 2016
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunitiesRichard Macrez, Peter K Stys, Denis Vivien, et al.
The Lancet. Neurology|April 25, 2018
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trialSonoko Misawa, Satoshi Kuwabara, Yasunori Sato, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
The Lancet. Neurology|February 17, 2015
Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial, Hugh S Markus, Elizabeth Hayter, et al.
The Lancet. Neurology|March 2, 2015
Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint studyXuya Huang, Bharath Kumar Cheripelli, Suzanne M Lloyd, et al.
The Lancet. Neurology|September 8, 2012
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort studyMaarten G Lansberg, Matus Straka, Stephanie Kemp, et al.
The Lancet. Neurology|February 10, 2015
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing studyManabu Funayama, Kenji Ohe, Taku Amo, et al.
The Lancet. Neurology|April 7, 2015
Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective studyParvathi Menon, Nimeshan Geevasinga, Con Yiannikas, et al.
The Lancet. Neurology|March 17, 2015
Pathological mechanisms in progressive multiple sclerosisDon H Mahad, Bruce D Trapp, Hans Lassmann
Pageof 199